Study finds no clear pregnancy risks from early GLP‑1 drug exposure
A new analysis of nearly 3,600 pregnancies found no clear rise in miscarriage, fetal growth problems, or major birth defects among women who continued using GLP‑1 weight‑loss drugs into early pregnancy.